Stambler BS, Plat F, Sager PT, Lubkov V, et al. Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia. Am Heart J 2022;253:20-29.
PMID: 35728658